Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232

GSK2838232 (GSK232) is a novel maturation inhibitor that blocks the proteolytic cleavage of HIV-1 Gag at the junction of capsid and spacer peptide 1 (CA/SP1), rendering newly-formed virions non-infectious. To our knowledge, GSK232 has not been tested against HIV-2, and there are limited data regardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Robert A., Raugi, Dana N., Nixon, Robert S., Song, Jennifer, Seydi, Moussa, Gottlieb, Geoffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847912/
https://www.ncbi.nlm.nih.gov/pubmed/36652466
http://dx.doi.org/10.1371/journal.pone.0280568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847912/
https://www.ncbi.nlm.nih.gov/pubmed/36652466
http://dx.doi.org/10.1371/journal.pone.0280568

Ejemplares similares